Jefferies Group News
News on Jefferies Group (Ticker: JEF) continually updated from thousands of sources around the net.
Should America ever negotiate with terrorists?
Should public schools teach Evolution or Creationism?
Shares of Regency Centers Corp. hit a new 52-week low on Wednesday, AR Network reports.
A number of other firms have also recently commented on ENZY. Analysts at Bank of America Corp. downgraded shares of Enzymotec Ltd from a "buy" rating to an "underperform" rating in a research note to investors on Wednesday.
Check below for free stories on DDD;BRCD;CAR;CHRW;CST;CIEN;CSCO;GLW;DPM;EHTH;EQM;ERIC;FFIV;HTZ;IT;IHS;JNPR;MHFI;MSI;NLSN;NOK;SSYS;RVBD;VJET;VRSK;TRGP;RKUS;RHT;CCJ;TWTR the last two weeks.
's stock had its "hold" rating reiterated by equities research analysts at Jefferies Group in a research note issued to investors on Wednesday, American Banking News.com reports.
's stock had its "buy" rating reaffirmed by investment analysts at Jefferies Group in a note issued to investors on Wednesday, StockRatingsNetwork.com reports.
Shares of Artisan Partners Asset Management hit a new 52-week high during trading hours on Monday, AnalystRatings.NET reports.
The firm currently has a "buy" rating on the stock. Jefferies Group's price target indicates a potential upside of 8.15% from the company's current price.
The firm currently has a "hold" rating on the stock. Jefferies Group's target price would suggest a potential upside of 5.49% from the company's current price.
The Dow Jones Industrial Average has spent the morning treading water below the breakeven mark, as investors fret about the eventual slowing of the Federal Reserve's current asset-buying program.
The firm set a "buy" rating and a $13.00 price target on the stock. Jefferies Group's price target would suggest a potential upside of 52.40% from the stock's previous close.
Shares of Magellan Health Services hit a new 52-week high on Monday, AR Network reports.
Other equities research analysts have also recently issued reports about the stock.
Celldex Therapeutics, Inc. today announced that the underwriters of its previously announced public offering of common stock have exercised in full their option to purchase an additional 1,050,000 additional shares of common stock at the public offering price of $24.50.
Item 1.01 Entry into a Material Definitive Agreement. On December 6, 2013 , Orchard Acquisition Company, LLC , an indirect subsidiary of JGWPT Holdings Inc. , and Jefferies Finance LLC entered into a second amendment to the Credit Agreement, dated as of February 8, 2013 , by and among Orchard Acquisition Company, LLC , as the Parent Borrower, J.G.